“hair loss”的搜索结果，显示 451-460 项，共有 13628 项

1. 外科 - 临床试验- 妙佑医疗国际

   ... growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability ...

2. 血液科- 临床试验- 妙佑医疗国际

   ... growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial will also study the ...

3. 妙佑医疗国际 - 黑棘皮症

   黑棘皮症是一种皮肤病，可能导致身体皱襞和褶皱中形成深色区域。它通常会影响腋窝、腹股沟和颈部。 Share · Tweet; WeChat. WeChat. Close. Weibo. July 30, 2022 ...

4. 外科 - 临床试验- 妙佑医疗国际

   The purpose of this study is to collect adult human blood, cerebrospinal fluid, brain, and spine tissues/fluids at time of surgery in order to conduct ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Olaparib and cediranib maleate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib, cediranib maleate, and ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Olaparib and cediranib maleate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib, cediranib maleate, and ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... growth of tumor cells, either by killing the cells or by stopping them from dividing. Cetuximab is a monoclonal antibody that may interfere with the ability ...

9. 外科 - 临床试验- 妙佑医疗国际

   The Mayo Clinic Upper Digestive Disease Survey has been created in order to have a consistent evaluation tools for patients undergoing esophageal ...

10. 减重：助力减重成功的6 个策略- 妙佑医疗国际

    数以百计的时尚饮食、减重项目和彻头彻尾的骗局都保证能快速、轻松地减轻体重。但是，减重并保持减重效果的最好方法，是持久地改变生活方式。这些健康的改变包括均衡 ...